Abigail Brooks

The organizations challenge a presidential executive order narrowing routine childhood vaccine recommendations and urging vaccines to be given separately.

Insulin icodec is now available in the US after FDA approval, offering adults with type 2 diabetes a once-weekly basal insulin option.

Experts discussed FCS diagnostic scoring tools, diagnostic delays, and new data on olezarsen and plozasiran for lowering triglycerides in a recent clinical forum.

With another execution set for Thursday, questions still surround Dr. Mark Walton Fowler's qualifications in the wake of a prior execution that was halted after 90 minutes.

Dr. Mark Walton Fowler says he declared Hines' time of death. The execution contrasts with a previous one that had problems with the insertion of IV lines.

The FDA approved an autoinjector device for lerodalcibep-liga and an updated indication reflecting cardiovascular risk reduction.

Phase 3 LUCIDITY results showed avexitide reduced Level 2 and Level 3 hypoglycemic events by 55% vs placebo in post-bariatric hypoglycemia.

FDA approved garetosmab for adults with FOP after phase 3 data showed fewer new HO lesions and clinician-assessed flare-ups vs placebo.

FDA authorized Aletta, a robotic venous blood collection device for supervised outpatient use, through the De Novo pathway.

FDA authorized Abbott’s Libre Duo 10 Day system, the first wearable device to continuously monitor both glucose and ketones.